<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Nursing Product Guide &#187; BioRx</title>
	<atom:link href="http://www.nursingproductguide.com/blog/tag/biorx/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.nursingproductguide.com/blog</link>
	<description>A comprehensive guide to nursing products for medical professionals</description>
	<lastBuildDate>Fri, 11 Jun 2010 11:30:43 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.8.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>BioRx Offers Berinert to Patients with Hereditary Angioedema</title>
		<link>http://www.nursingproductguide.com/blog/2009/12/23/biorx-offers-berinert-to-patients-with-hereditary-angioedema/</link>
		<comments>http://www.nursingproductguide.com/blog/2009/12/23/biorx-offers-berinert-to-patients-with-hereditary-angioedema/#comments</comments>
		<pubDate>Wed, 23 Dec 2009 10:17:48 +0000</pubDate>
		<dc:creator>Jim Marino</dc:creator>
				<category><![CDATA[Patient Care]]></category>
		<category><![CDATA[Berinert®]]></category>
		<category><![CDATA[BioRx]]></category>
		<category><![CDATA[CSL Behring]]></category>
		<category><![CDATA[hereditary angioedema]]></category>

		<guid isPermaLink="false">http://www.nursingproductguide.com/blog/?p=178</guid>
		<description><![CDATA[BioRx has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.nursingproductguide.com/blog/wp-content/uploads/2009/12/BioRx.png"><img class="alignleft size-full wp-image-179" style="margin: 5px" src="http://www.nursingproductguide.com/blog/wp-content/uploads/2009/12/BioRx.png" border="0" alt="BioRx" width="200" height="113" /></a>BioRx has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their distribution network to launch this exciting new product in the United States.</p>
<p>For the full story, <a href="http://www.pharmalive.com/News/index.cfm?articleid=671910&amp;categoryid=10" target="_blank">Click Here</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.nursingproductguide.com/blog/2009/12/23/biorx-offers-berinert-to-patients-with-hereditary-angioedema/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
